Vivos Therapeutics (VVOS) Net Equity Issued and Repurchased (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Net Equity Issued and Repurchased of $342000.0 for Q1 2026, down 87.79% quarter-over-quarter from $2.8 million in Q4 2025.
Vivos Therapeutics (VVOS) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Net Equity Issued and Repurchased for 5 consecutive years, with $342000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $342000.0; the TTM figure through Mar 2026 stood at $9.0 million (changed N/A YoY), while the FY2025 annual figure was $5.6 million, down 28.48% from the prior year.
- Net Equity Issued and Repurchased fell to $342000.0 in Q1 2026 per VVOS's latest filing, from $2.8 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $3.5 million in Q4 2024 and bottomed at $342000.0 in Q1 2026.
- Historically, Net Equity Issued and Repurchased has averaged $2.3 million across 3 years, with a median of $2.6 million in 2025.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 19.97% in 2025 and fell as far as 19.97% in 2025.
- Vivos Therapeutics' Net Equity Issued and Repurchased stood at $3.5 million in 2024, then retreated by 19.97% to $2.8 million in 2025, then tumbled by 87.79% to $342000.0 in 2026.
- Business Quant data shows VVOS's Net Equity Issued and Repurchased at $342000.0 in Q1 2026, $2.8 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | - |
| 10 | Vivos Therapeutics | 4.96 Mn | 3.16 Mn | 2.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 342,000.00 |
| Mar 31, 2026 | 342,000.00 |
| Dec 31, 2025 | 2.80 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Dec 31, 2024 | 3.50 Mn |
| Dec 31, 2024 | 3.50 Mn |
| Sep 30, 2021 | 330,000.00 |
| Sep 30, 2021 | 330,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Dec 31, 2020 | 22.29 Mn |
| Dec 31, 2020 | 22.29 Mn |